Orange County Retina Med Group

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Macular degeneration4 trials

Phase

• Phase 32 trials
• Phase 1/21 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Hoffmann-La Roche3 trials
• Genentech, Inc.1 trial

Running trials

• Active, not recruiting

  A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

  NCT04853251· Phase 4· Genentech, Inc.· Source

• Recruiting

  Extension Study for the Port Delivery System With Ranibizumab (Portal)

  NCT03683251· Phase 3· Hoffmann-La Roche· Source

Closed trials

• Completed

  A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT04777201· Phase 3· Hoffmann-La Roche· Source

• Completed

  Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration

  NCT04567303· Phase 1/2· Hoffmann-La Roche· Source